Spots Global Cancer Trial Database for infiltrating bladder urothelial carcinoma
Every month we try and update this database with for infiltrating bladder urothelial carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Bristol Bladder Trial | NCT01616875 | Infiltrating Bl... | Cabazitaxel + C... | 18 Years - | University Hospitals Bristol and Weston NHS Foundation Trust | |
Radiation Therapy and Pembrolizumab in Treating Patients With Localized Urothelial Bladder Cancer | NCT03419130 | Infiltrating Bl... Stage II Bladde... Stage III Bladd... | Hypofractionate... Laboratory Biom... Pembrolizumab Radiation Thera... | 18 Years - | University of California, San Francisco | |
Quality of Life After Bladder-Preservation Chemotherapy and Radiation Therapy in Patients With Muscle-Invasive Bladder Cancer | NCT02688348 | Infiltrating Bl... | Quality-of-Life... Questionnaire A... | 18 Years - | Jonsson Comprehensive Cancer Center | |
Radiation Therapy and Pembrolizumab in Treating Patients With Localized Urothelial Bladder Cancer | NCT03419130 | Infiltrating Bl... Stage II Bladde... Stage III Bladd... | Hypofractionate... Laboratory Biom... Pembrolizumab Radiation Thera... | 18 Years - | University of California, San Francisco | |
Bristol Bladder Trial | NCT01616875 | Infiltrating Bl... | Cabazitaxel + C... | 18 Years - | University Hospitals Bristol and Weston NHS Foundation Trust | |
sEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney Cancer | NCT02767921 | Infiltrating Bl... Recurrent Bladd... Stage I Prostat... Stage I Renal C... Stage II Bladde... Stage II Renal ... Stage IIA Prost... Stage IIB Prost... Stage III Prost... Stage III Renal... | Cytology Specim... Laboratory Biom... Radical Cystect... Recombinant Eph... Therapeutic Con... | 18 Years - | University of Southern California | |
Bristol Bladder Trial | NCT01616875 | Infiltrating Bl... | Cabazitaxel + C... | 18 Years - | University Hospitals Bristol and Weston NHS Foundation Trust | |
A Phase II Trial Evaluating an Organ-conserving Strategy by Radiochemotherapy for Muscle-infiltrative Bladder Cancer | NCT01495676 | Infiltrating Bl... | Radiation + cis... Radiation + cis... | 18 Years - | Institut du Cancer de Montpellier - Val d'Aurelle | |
Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing Surgery | NCT02944357 | Infiltrating Bl... Stage II Bladde... Stage III Bladd... Stage IV Bladde... | Cisplatin Gemcitabine Hyd... Radical Cystect... Tumor Cell-Deri... | 18 Years - | Mayo Clinic | |
Robot-Assisted Laparoscopic High-Intensity Focused Ultrasound and Radical Cystectomy for Thermal Ablation of Muscle Invasive Cells in Patients With Bladder Tumors | NCT03238664 | Infiltrating Bl... Stage II Bladde... Transitional Ce... | Biopsy High-Intensity ... Laboratory Biom... Radical Cystect... Ultrasonography | 18 Years - | University of Southern California | |
Robot-Assisted Laparoscopic High-Intensity Focused Ultrasound and Radical Cystectomy for Thermal Ablation of Muscle Invasive Cells in Patients With Bladder Tumors | NCT03238664 | Infiltrating Bl... Stage II Bladde... Transitional Ce... | Biopsy High-Intensity ... Laboratory Biom... Radical Cystect... Ultrasonography | 18 Years - | University of Southern California | |
NEoadjuvant Dose-dense MVAC In cOmbination With Durvalumab and Tremelimumab in Muscle-invasive Urothelial Carcinoma | NCT03549715 | Infiltrating Bl... | Durvalumab Tremelimumab MVAC Protocol | 18 Years - | Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie |